Navigation Links
DFG welcomes decision on stem cell research by German parliament

This release is available in German.

The President of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Professor Matthias Kleiner, commented on the decision by the German Federal Parliament on the Stem Cell Act:

The Deutsche Forschungsgemeinschaft is pleased and grateful for the decision taken by Parliament. We are especially grateful to those members of Parliament who contributed towards the critical debate of the issue.

The decision taken to move the qualifying date for importing human embryonic stem cell lines is a good and important step forwards for German science and for German stem cell researchers. They will take advantage of the new possibilities with a strong sense of responsibility and according to their strict ethical principles.

First and foremost, we are very glad that the threat of legal sanctions that has existed up to now has been lifted. This was a particularly serious deterrent for young researchers wanting to go abroad.

All in all, the debate on the amendment of the Stem Cell Act is another good example of constructive dialogue between the scientific community and politics. The outcome of todays debate is also firm evidence of the confidence in the scientific community and its ability to argue its case.


Contact: Dr. Eva-Maria Streier
Deutsche Forschungsgemeinschaft

Page: 1

Related biology news :

1. Unconscious decisions in the brain
2. Arctic climate models playing key role in polar bear decision
3. To save or savor? Its decision time for Atlantic bluefin tuna
4. More comprehensive analysis of Klamath River basin needed to aid decision makers
5. Decisions on the second round of the Excellence Initiative announced
6. Cilia: small organelles, big decisions
7. American College of Medical Genetics responds to new FDA labeling decision for warfarin
8. McMaster University engineering professor receives Humboldt Research Award
9. Purdue researchers propose way to incorporate deforestation into climate change treaty
10. Inflammation triggers cell fusions that could protect neurons, Stanford research shows
11. Research identifies first method for testing, assessing drug treatments for Chagas disease
Post Your Comments:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology: